3Ceccotti P, Leen E, Kalogeropoulou CP, et al. Portal vein thrombosis may alter the correct evaluation of hepatocellular carcinoma with the sono- graphic contrastpulse sequence technique. J Ultrasound Med, 2006,25 : 1619-1623.
2Nicolau C,Catala V,Vilana R,et al.Evaluation of hepatocellular carcinoma using SonoVue,a second generation ultrasound contrast agent:correlation with cellular differentiation.Eur Radiol,2004,14:1092-1099.
3Edmondson HA,Steiner PE.Primary carcinoma of the liver:a study of 100 cases among 18,900 necropsies.Cancer,1954,7:462-503.
4EFSUMB Study Group.Guidelines for the use of contrast agents in ultrasound.Ultraschall in Med,2004,25:249-256.
5Hayashi M,Matsui O,Ueda K,et al.Progression to hypervascular hepatocellular carcinoma:Correlation with intranodular bloodsupply evaluated with CT during intraarterial injection of contrast material.Radiology,2002,225:143-149.
6Matsui O,Kadoya M,Kameyama T,et al.Benign and malignant nodules in cirrhotic livers:distinction based on blood supply.Radiology,1991,178:493-497.
7Lencioni R,Pinto F,Armillotta N,et al.Assessment of tumor vascularity in hepatocellular carcinoma:comparison of power Doppler US and color Doppler US.Radiology,1996,201:353-358.
8Gaiani S,Casali A,Serra C,et al.Assessment of vascular patterns of small liver mass lesions:value and limitation of the different Doppler ultrasound modalities.Am J Gastroenterol,2000,95:3537-3546.
9Quaia E,Calliada F,Bertolotto M,et al.Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent:diagnostic performance and confidence.Radiology,2004,232:420-430.
9FurIan, A.,Marin, D.,Cabassa, P. et al. Enhancement pattern of small hepatocellular carcinoma (HCC) at contrast-enhanced US (CEUS), MDCT, and MRI: Intermodality agreement and comparison of diagnostic sensitivity between 2005 and 2010 American Association for 'the Study of Liver Diseases (AASLD) guidelines[J].European Journal of Radiology, 2012, 81 (9) : 2099- 2105.
10Yanzhao Zhao et al. Design assessment of Qi Yao, Hut tan and preliminary - (99m) Tc-1 abe 1 ed ultrasmall superparamagnetic iron oxide-conjugated bevacizumab for single photon emission computed tomography/ magnetic resonance imaging of hepatocellular carcinoma[J]. Journal of Radioanalytical and Nuclear Chemistry: An International Journal Dealing with All Aspects and Applications of Nuclear Chemistry, 2014,299(3):1273- 1280.
